Thrombocytopenia Secondary to COVID-19 Vaccination: Side Effect or Coincidence?

被引:0
作者
Khan, Simin [1 ]
Rehmani, Muhammed Noman [1 ]
Kasabali, Ahmad [1 ]
Thomas, Alfred [1 ]
Nguyen, Vinh [1 ]
机构
[1] Louisiana State Univ Hlth Shreveport, Internal Med, Shreveport, LA 71103 USA
关键词
booster vaccine; sjogren's; immune thrombocytopenia; vaccine; covid-19;
D O I
10.7759/cureus.38219
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
While widespread coronavirus disease 2019 (COVID-19) vaccination has helped achieve some control of the pandemic, vaccines have presented with side effects of their own, both common and rare. We present an unusual case of a 66-year-old who presented with severe thrombocytopenia following vaccination with the Pfizer-BioNTech mRNA vaccine. Our patient is a 66-year-old African American female with a known history of Sjogren's syndrome and hepatitis C who presented to our facility as a direct admit from our affiliated infusion clinic where routine lab work revealed a platelet count of 14,000. On arrival, she reported a one-month history of progressive tiredness, intermittent epistaxis, and bruising on her legs. Her physical exam was notable for multiple petechiae and non-palpable purpura on all four extremities. Further questioning revealed that she had received her COVID-19 vaccine booster (Pfizer-BioNTech) three weeks prior to presentation and that is when all the symptoms had started. Rheumatology was consulted and the patient was started on intravenous immunoglobulin infusion for two days and pulse dose prednisone. Her platelet count showed improvement after treatment, and she was discharged home with a platelet count of 42,000. Though largely safe and efficacious, COVID-19 vaccines can present with rare systemic side effects and physicians must have a high index of suspicion and report these cases so that more data is available for interpretation.
引用
收藏
页数:3
相关论文
共 8 条
  • [1] [Anonymous], 2022, COVID 19 VACCINE SAF
  • [2] [Anonymous], 2022, STAY DATE COVID 19 V
  • [3] [Anonymous], 2022, COMIRNATY PFIZER BIO
  • [4] [Anonymous], 2022, FDA APPROVES 1 COVID
  • [5] David P, 2021, ISR MED ASSOC J, V23, P378
  • [6] Immune Thrombocytopenia
    Kistangari, Gaurav
    McCrae, Keith R.
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 27 (03) : 495 - +
  • [7] Shimabukuro T, 2021, MMWR-MORBID MORTAL W, V70, P46, DOI [10.15585/mmwr.mm7004e1externalicon, 10.1111/ajt.16516]
  • [8] Emerging Concepts in Immune Thrombocytopenia
    Swinkels, Maurice
    Rijkers, Maaike
    Voorberg, Jan
    Vidarsson, Gestur
    Leebeek, Frank W. G.
    Jansen, A. J. Gerard
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9